Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The RNA interference pathway: a new target for autoimmunity.

Ger J M Pruijn1

  • 1Department of Biochemistry, Radboud University Nijmegen, Nijmegen, The Netherlands. G.Pruijn@ncmls.ru.nl

Arthritis Research & Therapy
|June 30, 2006
PubMed
Summary

Autoantibodies in autoimmune diseases target RNA interference (RNAi) machinery, including Argonaute and Dicer proteins. This finding suggests a potential link between RNAi, autoimmunity, and viral infections.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

International expert consensus recommendations on standardised nomenclature of SSA/Ro (TROVE2/Ro60 and TRIM21/Ro52) autoantibodies in autoimmune diseases.

Annals of the rheumatic diseases·2026
Same author

A New Immunofluorescence Assay Allows the Sensitive Detection of Anti-Cytosolic 5'-Nucleotidase 1A Autoantibodies.

European journal of immunology·2026
Same author

Anti-citrullinated protein antibody detection by hemagglutination.

Rheumatology advances in practice·2025
Same author

Circulating tRNA-derived fragments are decreased in patients with rheumatoid arthritis and increased in patients with psoriatic arthritis.

Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals·2024
Same author

IL-6 and TNF are Potential Inflammatory Biomarkers in Facioscapulohumeral Muscular Dystrophy.

Journal of neuromuscular diseases·2024
Same author

Citrulline is not a major determinant of autoantibody reactivity to neutrophil extracellular traps.

Philosophical transactions of the Royal Society of London. Series B, Biological sciences·2023

Area of Science:

  • Molecular Biology
  • Immunology
  • Autoimmunity

Background:

  • Systemic autoimmune diseases often involve autoantibodies targeting intracellular macromolecular complexes.
  • RNA interference (RNAi) is a crucial gene silencing pathway involving mRNA degradation or translational suppression.
  • The Su autoantigen complex, previously enigmatic, has been identified to contain key RNA interference machinery components.

Discussion:

  • Anti-Su autoantibodies from human patients and animal models recognize Argonaute and Dicer proteins, essential enzymes in the RNAi pathway.
  • The study raises questions about the triggers for the anti-Su autoantibody response.
  • Potential involvement of molecular modifications, similar to other autoantigens, is considered.

Key Insights:

  • The Su autoantigen complex is directly implicated in the RNA interference pathway.

Related Experiment Videos

  • Autoimmunity in rheumatic diseases involves antibodies against critical RNAi enzymes.
  • The RNAi pathway's role in antiviral defense may link viral infections to the anti-Su response.

    • Outlook:

    • Further research is needed to elucidate the precise mechanisms triggering the anti-Su autoantibody response.
    • Investigating the role of molecular modifications in initiating autoimmunity against RNAi components is warranted.
    • Exploring the potential contribution of viral infections to the development of anti-Su autoimmunity is a key future direction.